PreTT ApS
PrivateLast Round
Grant
Feb 24, 2026
Total Funding Raised
$5.11M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PreTT ApS operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Grant round in February 2026.
PreTT ApS is a biotechnology company that develops pretargeted radioligand therapy platforms to improve the precision and effectiveness of cancer treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PreTT ApS Comparables
Compare PreTT ApS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoOne | 86% | |
| Akiram Therapeutics | 81% | |
| Tagworks Pharmaceuticals | 77% |
For institutional investors. Book with your work email.
PreTT ApS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 24, 2026 | ||||
| Grant | Apr 3, 2025 | ||||
| Accelerator | Feb 29, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PreTT ApS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| Eurostars SME programme | Grant |
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 3, 2026
Grew 75% QoQ from 4 to 7 employees.
- Feb 29, 2024
$541K raised from BioInnovation Institute
For institutional investors. Book with your work email.
PreTT ApS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PreTT ApS's valuation, stock price, and market status.
Is PreTT ApS a public or private company?
PreTT ApS is a private company.
What is the current stock price of PreTT ApS?
PreTT ApS is a private company, so its shares have no public market price. Caplight tracks PreTT ApS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PreTT ApS worth (valuation)?
Valuation information for PreTT ApS is not publicly available.
Can I buy PreTT ApS stock?
PreTT ApS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PreTT ApS's last funding round?
PreTT ApS's most recent funding round was Grant on February 24, 2026.
Who are the main investors in PreTT ApS?
Key investors in PreTT ApS include Innovation Fund Denmark, Eurostars SME programme, BioInnovation Institute.
Will PreTT ApS IPO soon?
No public IPO plans have been announced for PreTT ApS.
How can I track PreTT ApS secondary market activity?
Caplight tracks bids, offers, and trades in PreTT ApS's shares on secondary markets.